tiprankstipranks

Matthew Maxwell Donley Insider Profile

4 Followers
Matthew Maxwell Donley, EVP, Global HR, IT & Strategy at Sucampo Pharmaceuticals, holds 584.07K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 36.98K shares in Sucampo Pharmaceuticals (Ticker: SCMP). Most recently, Matthew Maxwell Donley Sold ― shares of Aurinia Pharmaceuticals on Mar 07, 2024 for an estimated value of 224.06K.
tipranks
Matthew Maxwell Donley

Matthew Maxwell Donley
Sucampo Pharmaceuticals (SCMP)
EVP, Global HR, IT & Strategy

Ranked #40,755 out of 97,825 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+4.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Matthew Maxwell Donley's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
EVP, Ops & Strategy
Roles that Matthew Maxwell Donley holds in companies

Most Profitable Insider Trade

Stock:
Aurinia Pharmaceuticals
(AUPH)
Rating:Informative Sell
Date:Mar 04, 2022 - Mar 04, 2023
Return:+15.00%
The most profitable trade made by Matthew Maxwell Donley

Matthew Maxwell Donley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
Uninformative Sell
665.55K
$665.55K
Aurinia Pharmaceuticals
Mar 07, 2024
EVP, Ops & Strategy
Informative Sell
224.06K
$2.92M
List of latest transactions for each holding click on a transaction to see Matthew Maxwell Donley's performance on stock

Matthew Maxwell Donley insider profile FAQ

What is the percentage of profitable transactions made by Matthew Maxwell Donley?
The percentage of profitable transactions made by Matthew Maxwell Donley is 67%.
    What is the average return per transaction made by Matthew Maxwell Donley?
    The average return per transaction made by Matthew Maxwell Donley is 4.60%.
      What stocks does Matthew Maxwell Donley hold?
      Matthew Maxwell Donley holds: SCMP, AUPH stocks.
        What was Matthew Maxwell Donley’s latest transaction?
        Matthew Maxwell Donley latest transaction was an Informative Sell of $224.06K.
          What was Matthew Maxwell Donley's most profitable transaction?
          Matthew Maxwell Donley’s most profitable transaction was an Informative Sell of AUPH stock on March 4, 2022. The return on the trade was 15.00%.
            What is Matthew Maxwell Donley's role in Sucampo Pharmaceuticals?
            Matthew Maxwell Donley's role in Sucampo Pharmaceuticals is EVP, Global HR, IT & Strategy.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.